TrialBritish journal of cancer2004

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks.

T Kerbusch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.